A serological survey on neutralizing antibody titer of SARS convalescent sera - PubMed (original) (raw)
Jiang-Ting Chen, Yu-Xuan Liu, Zhen-Shan Zhang, Hong Gao, Yan Liu, Xu Wang, Ye Ning, Yu-Fen Liu, Qiang Gao, Jian-Guo Xu, Chuan Qin, Xiao-Ping Dong, Wei-Dong Yin
Affiliations
- PMID: 16121363
- PMCID: PMC7167078
- DOI: 10.1002/jmv.20431
A serological survey on neutralizing antibody titer of SARS convalescent sera
Jian-San Zhang et al. J Med Virol. 2005 Oct.
Abstract
A seroepidemiologic study was conducted in North China in 2003 to determine the neutralizing antibody titer of severe acute respiratory syndrome (SARS) convalescent sera. A total of 99 SARS convalescent serum samples were collected from patients from the Inner Mongolia Autonomous Region, Hebei Province, and Beijing 35-180 days after the onset of symptoms. The anti-SARS antibodies were detected by enzyme-linked immunosorbent assay (ELISA), neutralization assay, and Western blot. Eighty-seven serum samples were confirmed to be positive for SARS antibodies. The neutralizing antibody titer of the 87 positive sera was analyzed quantitatively by neutralization assay. The geometric mean titer (GMT) of the 87 convalescent sera was 1:61. The Kolmogorov-Smirnov test showed that the neutralizing antibody titers conform to normal distribution, which suggests that the average anti-SARS antibody level in this study was representative of the convalescent antibody level of the SARS population. This result could be useful for the development and quality control of SARS vaccines.
(c) 2005 Wiley-Liss, Inc
Similar articles
- Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients.
Shi Y, Wan Z, Li L, Li P, Li C, Ma Q, Cao C. Shi Y, et al. J Clin Virol. 2004 Sep;31(1):66-8. doi: 10.1016/j.jcv.2004.05.006. J Clin Virol. 2004. PMID: 15288616 Free PMC article. - Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests.
Chan KH, Chan JF, Tse H, Chen H, Lau CC, Cai JP, Tsang AK, Xiao X, To KK, Lau SK, Woo PC, Zheng BJ, Wang M, Yuen KY. Chan KH, et al. J Infect. 2013 Aug;67(2):130-40. doi: 10.1016/j.jinf.2013.03.015. Epub 2013 Apr 10. J Infect. 2013. PMID: 23583636 Free PMC article. - Preparation and characterization of SARS in-house reference antiserum.
Zhang J, Liu Y, Hu L, Gao Q, Zhang Z, Zhang X, Chen J, Gong X, Song L, Liu Y, Li J, Li S, Huang J, Ning Y, Gao H, Qin C, Dong X, Wei J, Dong G, Yin W. Zhang J, et al. Vaccine. 2005 Dec 1;23(48-49):5666-9. doi: 10.1016/j.vaccine.2004.12.032. Epub 2005 Mar 16. Vaccine. 2005. PMID: 16269206 Free PMC article. - Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma.
Zhang Z, Xie YW, Hong J, Zhang X, Kwok SY, Huang X, Wong SW, Wong BL; SARSIg Group. Zhang Z, et al. Transfusion. 2005 Jul;45(7):1160-4. doi: 10.1111/j.1537-2995.2005.00179.x. Transfusion. 2005. PMID: 15987362 Free PMC article. - The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. Mair-Jenkins J, et al. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. J Infect Dis. 2015. PMID: 25030060 Free PMC article. Review.
Cited by
- Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19.
Bohoněk M, Máca J, Sagan J, Řezáč D, Fridrich V, Burantová A, Kutáč D, Vabroušek P, Kubů J, Chrdle A, Volfová K, Blahutová Š, Rychlík I, Vonášková K, Majerčin R, Králová R, Štěpánek P, Holub M. Bohoněk M, et al. Virol J. 2024 Sep 30;21(1):239. doi: 10.1186/s12985-024-02475-y. Virol J. 2024. PMID: 39350163 Free PMC article. - Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19.
Hashem M, El-Kassas M. Hashem M, et al. World J Clin Cases. 2023 Apr 6;11(10):2140-2159. doi: 10.12998/wjcc.v11.i10.2140. World J Clin Cases. 2023. PMID: 37122505 Free PMC article. Review. - Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review.
Kandula UR, Tuji TS, Gudeta DB, Bulbula KL, Mohammad AA, Wari KD, Abbas A. Kandula UR, et al. J Blood Med. 2023 Feb 22;14:159-187. doi: 10.2147/JBM.S397722. eCollection 2023. J Blood Med. 2023. PMID: 36855559 Free PMC article. Review. - Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers.
Mouna L, Razazian M, Duquesne S, Roque-Afonso AM, Vauloup-Fellous C. Mouna L, et al. Viruses. 2023 Feb 2;15(2):426. doi: 10.3390/v15020426. Viruses. 2023. PMID: 36851641 Free PMC article. - Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population.
Roy D, Rahman MM, Chaity AS, Reza MA, Haque A. Roy D, et al. Sci Rep. 2022 Aug 29;12(1):14681. doi: 10.1038/s41598-022-18302-9. Sci Rep. 2022. PMID: 36038600 Free PMC article.
References
- Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967–1976. - PubMed
- Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S, Escriou N, Manuguerra JC, Stohr K, Peiris JS, Osterhaus AD. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362: 263–270. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous